Direct Relief, the National Association of Free and Charitable Clinics and Teva Pharmaceuticals Partner to Advance Access to Behavioral Health Services | Business Wire
Teva Pays $420 Million to End Generic-Drug Securities Suit (1)
Teva Reaches Agreement With Georgia to Settle the State's Price Fixing Claims | Business Wire